Argent Capital Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-93,200
Closed -$1.4M 211
2016
Q2
$1.4M Buy
93,200
+17,775
+24% +$228K 0.06% 117
2016
Q1
$918K Buy
+75,425
New +$1.06M 0.04% 128

Argent Capital Management's SGNT Position: Q3 2016 in Review

Argent Capital Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 93,200 shares — an estimated $1.4M sold.

Argent Capital Management first reported a position in SGNT in Q1 2016 and held it in 2 quarters. The position peaked at $1.4M in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Argent Capital Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Argent Capital Management sold 93,200 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $1.4M.
  • Argent Capital Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2016 and held it in 2 quarters.
  • Argent Capital Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.4M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Argent Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.